ZEUS - Effects of ziltivekimab versus placebo on cardiovascular outcomes in participants with established atherosclerotic cardiovascular disease chronic kidney disease and systemic inflammation

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Cardiovascular Disease, Chronic Kidney Disease
  • Age: Between 18 Year(s) - 100 Year(s)
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. Estimated glomerular filtration rate (eGFR) between 15 and 60.

You may not be eligible for this study if the following are true:

    1. Female who is pregnant, breast-feeding or intends to become pregnant.
    2. HbA1c = 10%.
    3. History of recurrent serious infections (infections leading to hospitalization or use of i.v. antibiotics) in the 12 months prior to r

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.